FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 318:76-81 January 14, 1988 Number 2 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We estimated the risk of second cancers among 1507 patients with Hodgkin's disease treated at Stanford University Medical Center since 1968. Eight-three second cancers occurred more than one year after diagnosis, as compared with 15.9 expected on the basis of rates in the general population (relative risk, 5.2; 95 percent confidence interval, 4.2 to 6.5). The mean (+/- SE) 15-year actuarial risk of all second cancers was 17.6 +/- 3.1 percent, of which 13.2 +/- 3.1 percent was due to solid tumors. The risk of leukemia appeared to reach a plateau level of 3.3 +/- 0.6 percent at 10 years, whereas non-Hodgkin's lymphoma continued to increase, to 1.6 +/- 0.7 percent by the end of the follow-up period. The risk of solid tumors did not vary significantly according to treatment category, with the array of neoplasms resembling that previously observed in populations exposed to radiation and in immunosuppressed groups. The risk of leukemia, although elevated after radiation therapy alone (relative risk, 11; 95 percent confidence interval, 1.2 to 38), was much higher after either adjuvant chemotherapy (relative risk, 117; 95 percent confidence interval, 69 to 185) or chemotherapy alone (relative risk, 130; 95 percent confidence interval, 26 to 380). These data suggest that the risk of solid tumors after therapy for Hodgkin's disease continues to increase with time.

Source Information

Environmental Epidemiology Branch, National Cancer Institute, Bethesda, MD. 20892.

This article has been cited by other articles:

• Chakraborty, S., Sun, C.-L., Francisco, L., Sabado, M., Li, L., Chang, K. L., Forman, S., Bhatia, S., Bhatia, R. (2009). Accelerated Telomere Shortening Precedes Development of Therapy-Related Myelodysplasia or Acute Myelogenous Leukemia After Autologous Transplantation for Lymphoma. JCO 27: 791-798 [Abstract] [Full Text]  
• Krishnan, B., Morgan, G. J. (2007). Non-Hodgkin Lymphoma Secondary to Cancer Chemotherapy. Cancer Epidemiol. Biomarkers Prev. 16: 377-380 [Abstract] [Full Text]  
• Castiglioni, F., Terenziani, M., Carcangiu, M. L., Miliano, R., Aiello, P., Bertola, L., Triulzi, T., Gasparini, P., Camerini, T., Sozzi, G., Fossati-Bellani, F., Menard, S., Tagliabue, E. (2007). Radiation Effects on Development of HER2-Positive Breast Carcinomas. Clin. Cancer Res. 13: 46-51 [Abstract] [Full Text]  
• Franklin, J, Pluetschow, A, Paus, M, Specht, L, Anselmo, A-P, Aviles, A, Biti, G, Bogatyreva, T, Bonadonna, G, Brillant, C, Cavalieri, E, Diehl, V, Eghbali, H, Ferme, C, Henry-Amar, M, Hoppe, R, Howard, S, Meyer, R, Niedzwiecki, D, Pavlovsky, S, Radford, J, Raemaekers, J, Ryder, D, Schiller, P, Shakhtarina, S, Valagussa, P, Wilimas, J, Yahalom, J (2006). Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials. Ann Oncol 17: 1749-1760 [Abstract] [Full Text]  
• Landgren, O., Axdorph, U., Fears, T. R., Porwit-MacDonald, A., Wedelin, C., Bjorkholm, M. (2006). A population-based cohort study on early-stage Hodgkin lymphoma treated with radiotherapy alone: with special reference to older patients. Ann Oncol 17: 1290-1295 [Abstract] [Full Text]  
• Begg, C. B, Hummer, A. J, Mujumdar, U., Armstrong, B. K, Kricker, A., Marrett, L. D, Millikan, R. C, Gruber, S. B, Culver, H. A., Zanetti, R., Gallagher, R. P, Dwyer, T., Rebbeck, T. R, Busam, K., From, L., Berwick, M., for the GEM Study Group, (2006). A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma. Int J Epidemiol 35: 756-764 [Abstract] [Full Text]  
• Koontz, B. F., Kirkpatrick, J. P., Clough, R. W., Prosnitz, R. G., Gockerman, J. P., Moore, J. O., Prosnitz, L. R. (2006). Combined-Modality Therapy Versus Radiotherapy Alone for Treatment of Early-Stage Hodgkin's Disease: Cure Balanced Against Complications. JCO 24: 605-611 [Abstract] [Full Text]  
• Schonfeld, S. J., Gilbert, E. S., Dores, G. M., Lynch, C. F., Hodgson, D. C., Hall, P., Storm, H., Andersen, A., Pukkala, E., Holowaty, E., Kaijser, M., Andersson, M., Joensuu, H., Fossa, S. D., Allan, J. M., Travis, L. B. (2006). Acute Myeloid Leukemia Following Hodgkin Lymphoma: A Population-Based Study of 35 511 Patients. JNCI J Natl Cancer Inst 98: 215-218 [Abstract] [Full Text]  
• Forrest, D. L., Hogge, D. E., Nevill, T. J., Nantel, S. H., Barnett, M. J., Shepherd, J. D., Sutherland, H. J., Toze, C. L., Smith, C. A., Lavoie, J. C., Song, K. W., Voss, N. J., Gascoyne, R. D., Connors, J. M. (2005). High-Dose Therapy and Autologous Hematopoietic Stem-Cell Transplantation Does Not Increase the Risk of Second Neoplasms for Patients With Hodgkin's Lymphoma: A Comparison of Conventional Therapy Alone Versus Conventional Therapy Followed by Autologous Hematopoietic Stem-Cell Transplantation. JCO 23: 7994-8002 [Abstract] [Full Text]  
• Amemiya, K, Shibuya, H, Yoshimura, R, Okada, N (2005). The risk of radiation-induced cancer in patients with squamous cell carcinoma of the head and neck and its results of treatment. Br. J. Radiol. 78: 1028-1033 [Abstract] [Full Text]  
• Lenz, G., Dreyling, M., Schiegnitz, E., Haferlach, T., Hasford, J., Unterhalt, M., Hiddemann, W. (2004). Moderate Increase of Secondary Hematologic Malignancies After Myeloablative Radiochemotherapy and Autologous Stem-Cell Transplantation in Patients With Indolent Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group. JCO 22: 4926-4933 [Abstract] [Full Text]  
• Behringer, K., Josting, A., Schiller, P., Eich, H. T., Bredenfeld, H., Diehl, V., Engert, A. (2004). Solid tumors in patients treated for Hodgkin's disease: a report from the German Hodgkin Lymphoma Study Group. Ann Oncol 15: 1079-1085 [Abstract] [Full Text]  
• Palesty, J. A., Wang, W., Javle, M. M., Yang, G. Y. (2004). Side Effects of Therapy: CASE 3. Gastric Cancer After Radiotherapy of Pediatric Hodgkin's Disease. JCO 22: 2507-2509 [Full Text]  
• Maignan, C. l., Desablens, B., Delwail, V., Dib, M., Berthou, C., Vigier, M., Ghandour, C., Atmani, S., Casassus, P., Maisonneuve, H., Mevel, A. L., Traulle, C., Bernard, M., Briere, J., Colonna, P., Andrieu, J.-M. (2004). Three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) or epirubicin, bleomycin, vinblastine, and methotrexate (EBVM) plus extended field radiation therapy in early and intermediate Hodgkin disease: 10-year results of a randomized trial. Blood 103: 58-66 [Abstract] [Full Text]  
• Josting, A., Wiedenmann, S., Franklin, J., May, M., Sieber, M., Wolf, J., Engert, A., Diehl, V. (2003). Secondary Myeloid Leukemia and Myelodysplastic Syndromes in Patients Treated for Hodgkin's Disease: A Report From the German Hodgkin's Lymphoma Study Group. JCO 21: 3440-3446 [Abstract] [Full Text]  
• Aleman, B. M.P., Raemaekers, J. M.M., Tirelli, U., Bortolus, R., van 't Veer, M. B., Lybeert, M. L.M., Keuning, J. J., Carde, P., Girinsky, T., van der Maazen, R. W.M., Tomsic, R., Vovk, M., van Hoof, A., Demeestere, G., Lugtenburg, P. J., Thomas, J., Schroyens, W., De Boeck, K., Baars, J. W., Kluin-Nelemans, J. C., Carrie, C., Aoudjhane, M., Bron, D., Eghbali, H., Smit, W. G.J.M., Meerwaldt, J. H., Hagenbeek, A., Pinna, A., Henry-Amar, M., the European Organization for Research and Treatme, (2003). Involved-Field Radiotherapy for Advanced Hodgkin's Lymphoma. NEJM 348: 2396-2406 [Abstract] [Full Text]  
• Wahner-Roedler, D. L., Nelson, D. F., Croghan, I. T., Achenbach, S. J., Crowson, C. S., Hartmann, L. C., O'Fallon, W. M. (2003). Risk of Breast Cancer and Breast Cancer Characteristics in Women Treated With Supradiaphragmatic Radiation for Hodgkin Lymphoma: Mayo Clinic Experience. Mayo Clin Proc. 78: 708-715 [Abstract]  
• Radman, I., Basic, N., Labar, B., Kovacevic, J., Aurer, I., Bogdanic, V., Zupancic-Salek, S., Nemet, D., Jakic-Razumovic, J., Mrsic, M., Santek, F., Grgic-Markulin, L., Boban, D. (2002). Long-term results of conventional-dose salvage chemotherapy in patients with refractory and relapsed Hodgkin's disease (Croatian experience). Ann Oncol 13: 1650-1655 [Abstract] [Full Text]  
• Ng, A. K., Bernardo, M. V. P., Weller, E., Backstrand, K., Silver, B., Marcus, K. C., Tarbell, N. J., Stevenson, M. A., Friedberg, J. W., Mauch, P. M. (2002). Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood 100: 1989-1996 [Abstract] [Full Text]  
• Dores, G. M., Metayer, C., Curtis, R. E., Lynch, C. F., Clarke, E. A., Glimelius, B., Storm, H., Pukkala, E., van Leeuwen, F. E., Holowaty, E. J., Andersson, M., Wiklund, T., Joensuu, T., van't Veer, M. B., Stovall, M., Gospodarowicz, M., Travis, L. B. (2002). Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin's Disease: A Population-Based Evaluation Over 25 Years. JCO 20: 3484-3494 [Abstract] [Full Text]  
• Diller, L., Nancarrow, C. M., Shaffer, K., Matulonis, U., Mauch, P., Neuberg, D., Tarbell, N. J., Litman, H., Garber, J. (2002). Breast Cancer Screening in Women Previously Treated for Hodgkin's Disease: A Prospective Cohort Study. JCO 20: 2085-2091 [Abstract] [Full Text]  
• Travis, L. B., Gospodarowicz, M., Curtis, R. E., Aileen Clarke, E., Andersson, M., Glimelius, B., Joensuu, T., Lynch, C. F., van Leeuwen, F. E., Holowaty, E., Storm, H., Glimelius, I., Pukkala, E., Stovall, M., Fraumeni, J. F. Jr., Boice, J. D. Jr., Gilbert, E. (2002). Lung Cancer Following Chemotherapy and Radiotherapy for Hodgkin's Disease. JNCI J Natl Cancer Inst 94: 182-192 [Abstract] [Full Text]  
• Sanderson, B. J.S., Johnson, K. J., Henner, W.D. (2001). Induction of mutant lymphocytes in cyclophosphamide- and chlorambucil-treated patients. Mutagenesis 16: 197-202 [Abstract] [Full Text]  
• Rueffer, U., Josting, A., Franklin, J., May, M., Sieber, M., Breuer, K., Engert, A., Diehl, V. (2001). Non-Hodgkin's Lymphoma After Primary Hodgkin's Disease in the German Hodgkin's Lymphoma Study Group: Incidence, Treatment, and Prognosis. JCO 19: 2026-2032 [Abstract] [Full Text]  
• Swerdlow, A. J., Schoemaker, M. J., Allerton, R., Horwich, A., Barber, J. A., Cunningham, D., Lister, T. A., Rohatiner, A. Z.S., Vaughan Hudson, G., Williams, M. V., Linch, D. C. (2001). Lung Cancer After Hodgkin's Disease: A Nested Case-Control Study of the Relation to Treatment. JCO 19: 1610-1618 [Abstract] [Full Text]  
• Sureda, A., Arranz, R., Iriondo, A., Carreras, E., Lahuerta, J.J., Garcia-Conde, J., Jarque, I., Caballero, M.D., Ferra, C., Lopez, A., Garcia-Larana, J., Cabrera, R., Carrera, D., Ruiz-Romero, M.D., Leon, A., Rifon, J., Diaz-Mediavilla, J., Mataix, R., Morey, M., Moraleda, J.M., Altes, A., Lopez-Guillermo, A., de la Serna, J., Fernandez-Ranada, J.M., Sierra, J., Conde, E. (2001). Autologous Stem-Cell Transplantation for Hodgkin's Disease: Results and Prognostic Factors in 494 Patients From the Grupo Espanol de Linfomas/Transplante Autologo de Medula Osea Spanish Cooperative Group. JCO 19: 1395-1404 [Abstract] [Full Text]  
• Behrens, C., Travis, L. B., Wistuba, I. I., Davis, S., Maitra, A., Clarke, E. A., Lynch, C. F., Glimelius, B., Wiklund, T., Tarone, R., Gazdar, A. F. (2000). Molecular Changes in Second Primary Lung and Breast Cancers after Therapy for Hodgkin's Disease. Cancer Epidemiol. Biomarkers Prev. 9: 1027-1035 [Abstract] [Full Text]  
• Metayer, C., Lynch, C. F., Clarke, E. A., Glimelius, B., Storm, H., Pukkala, E., Joensuu, T., van Leeuwen, F. E., van't Veer, M. B., Curtis, R. E., Holowaty, E. J., Andersson, M., Wiklund, T., Gospodarowicz, M., Travis, L. B. (2000). Second Cancers Among Long-Term Survivors of Hodgkin's Disease Diagnosed in Childhood and Adolescence. JCO 18: 2435-2443 [Abstract] [Full Text]  
• Pedersen-Bjergaard, J., Andersen, M. K., Christiansen, D. H. (2000). Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation. Blood 95: 3273-3279 [Abstract] [Full Text]  
• Krishnan, A., Bhatia, S., Slovak, M. L., Arber, D. A., Niland, J. C., Nademanee, A., Fung, H., Bhatia, R., Kashyap, A., Molina, A., O'Donnell, M. R., Parker, P. A., Sniecinski, I., Snyder, D. S., Spielberger, R., Stein, A., Forman, S. J. (2000). Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood 95: 1588-1593 [Abstract] [Full Text]  
• van Leeuwen, F. E., Klokman, W. J., Veer, M. B. v.’t, Hagenbeek, A., Krol, A. D. G., Vetter, U. A. O., Schaapveld, M., van Heerde, P., Burgers, J. M. V., Somers, R., Aleman, B. M. P. (2000). Long-Term Risk of Second Malignancy in Survivors of Hodgkin’s Disease Treated During Adolescence or Young Adulthood. JCO 18: 487-487 [Abstract] [Full Text]  
• Swerdlow, A. J., Barber, J. A., Hudson, G. V., Cunningham, D., Gupta, R. K., Hancock, B. W., Horwich, A., Lister, T. A., Linch, D. C. (2000). Risk of Second Malignancy After Hodgkin’s Disease in a Collaborative British Cohort: The Relation to Age at Treatment. JCO 18: 498-498 [Abstract] [Full Text]  
• Linch, D. C., Gosden, R. G., Tulandi, T., Tan, S.-L., Hancock, S. L. (2000). Hodgkin's Lymphoma: Choice of Therapy and Late Complications. ASH Education Book 2000: 205-221 [Abstract] [Full Text]  
• Kolb, H. J., Socie, G., Duell, T., Van Lint, M. T., Tichelli, A., Apperley, J. F., Nekolla, E., Ljungman, P., Jacobsen, N., van Weel, M., Wick, R., Weiss, M., Prentice, H. G., for the Late Effects Working Party of the European, (1999). Malignant Neoplasms in Long-Term Survivors of Bone Marrow Transplantation. ANN INTERN MED 131: 738-744 [Abstract] [Full Text]  
• Ng, A. K., Weeks, J. C., Mauch, P. M., Kuntz, K. M. (1999). Decision Analysis on Alternative Treatment Strategies for Favorable-Prognosis, Early-Stage Hodgkin's Disease. JCO 17: 3577-3585 [Abstract] [Full Text]  
• Aisenberg, A. C. (1999). Problems in Hodgkin's Disease Management. Blood 93: 761-779 [Full Text]  
• Ng, A. K., Weeks, J. C., Mauch, P. M., Kuntz, K. M. (1999). Laparotomy Versus No Laparotomy in the Management of Early-Stage, Favorable-Prognosis Hodgkin's Disease: A Decision Analysis. JCO 17: 241-241 [Abstract] [Full Text]  
• Andre, M., Henry-Amar, M., Blaise, D., Colombat, P., Fleury, J., Milpied, N., Cahn, J.-Y., Pico, J.-L., Bastion, Y., Kuentz, M., Nedellec, G., Attal, M., Ferme, C., Gisselbrecht, C. (1998). Treatment-Related Deaths and Second Cancer Risk After Autologous Stem-Cell Transplantation for Hodgkin's Disease. Blood 92: 1933-1940 [Abstract] [Full Text]  
• Joseph, E., Clark, R., Berman, C., Miller, M., Cox, C., Greenberg, H., Reintgen, D. S. (1997). Screening Childhood Cancer Survivors for Breast Cancer. The Oncologist 2: 228-234 [Abstract] [Full Text]  
• Bhatia, S., Robison, L. L., Oberlin, O., Greenberg, M., Bunin, G., Fossati-Bellani, F., Meadows, A. T. (1996). Breast Cancer and Other Second Neoplasms after Childhood Hodgkin's Disease. NEJM 334: 745-751 [Abstract] [Full Text]  
• Donaldson, S. S., Hancock, S. L. (1996). Second Cancers after Hodgkin's Disease in Childhood. NEJM 334: 792-794 [Full Text]  
• Multani, P. S., Grossbard, M. L. (1996). Staging Laparotomy in the Management of Hodgkin's Disease: Is it Still Necessary?. The Oncologist 1: 41-55 [Abstract] [Full Text]  
• Grossbard, M. L., Harris, N. L. (1994). Case 10-1994- A 37-Year-Old Woman with Thrombocytopenia and a Paragastric Mass after Treatment for Hodgkin's Disease. NEJM 330: 698-704 [Full Text]  
• Kirsch, I.R., Abdallah, J.M., Bertness, V.L., Hale, M., Lipkowitz, S., Lista, F., Lombardi, D.P. (1994). Lymphocyte-specific Genetic Instability and Cancer. Cold Spring Harb Symp Quant Biol 59: 287-295 [Abstract]  
• Mauch, P. M., Ferry, J. A. (1993). Case 19-1993- A 39-Year-Old Man with Bilateral Renal Masses a Few Months after Treatment for Hodgkin's Disease, Stage IIA. NEJM 328: 1406-1414 [Full Text]  
• DeVita, V. T., Hubbard, S. M. (1993). Hodgkin's Disease. NEJM 328: 560-565 [Full Text]  
• Djulbegovic, B., Hollenberg, J., Woodcock, T. M., Herzig, R. (1991). Comparison of Different Treatment strategies for Diffuse Large-cell Lymphomas: A Decision Analysis. Med Decis Making 11: 1-8 [Abstract]  
• Davis, L. E. (1991). Long-Term Complications of Antineoplastic Agents. Journal of Pharmacy Practice 4: 131-150  
• Neugut, A. I., Robinson, E., Nieves, J., Murray, T., Tsai, W.-Y. (1990). Poor Survival of Treatment-Related Acute Nonlymphocytic Leukemia. JAMA 264: 1006-1008 [Abstract]  
• Loescher, L. J., Welch-McCaffrey, D., Leigh, S. A., Hoffman, B., Meyskens, F. L. Jr (1989). Surviving Adult Cancers. Part 1: Physiologic Effects. ANN INTERN MED 111: 411-432 [Abstract]  
• Bookman, M. A., Longo, D. L., Young, R. C. (1988). Late Complications of Curative Treatment in Hodgkin's Disease. JAMA 260: 680-683 [Abstract]  
• Hancock, S. L., Hoppe, R. T., Horning, S. J., Rosenberg, S. A. (1988). Intercurrent Death after Hodgkin Disease Therapy in Radiotherapy and Adjuvant MOPP Trials. ANN INTERN MED 109: 183-189 [Abstract]